EYEGATE PHARMACEUTICALS INC 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Jun 5, 2017
Insider Transaction Report
Form 4
CHANEY PAUL G
Director
Transactions
- Exercise/Conversion
Common Stock
2017-06-02$0.65/sh+17,570$11,421→ 41,229 total - Exercise/Conversion
Stock Option (right to buy)
2017-06-02−17,570→ 0 totalExercise: $0.65Exp: 2017-07-17→ Common Stock (17,570 underlying)
Footnotes (1)
- [F1]The reporting person was granted an option to purchase these shares pursuant to the Issuer's 2005 Equity Incentive Plan. The option became exercisable immediately at the time of grant.